Celldex Therapeutics Aktie

3,33 $ -0,89% -0,03 $
In Euro: 3,1028 € | 24.01.17 Nasdaq | Mehr Kurse »
WKN: A0RA0S
ISIN: US15117B1035
Symbol: CLDX
Typ: Aktie

Performance Celldex Therapeutics Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 3,50 $ 3,76 $ 3,26 $ 3,54 $ 10,69 $ 27,14 $
Änderung -4,86% -11,44% +2,15% -5,93% -68,85% -87,73%

Forum zur Celldex Therapeutics Aktie

Cobra7: Bad News
07.03.16
Data Safety and Monitoring Board Recommends Celldex's Phase 3 Study of RINTEGA® (rindopepimut) in Newly Diagnosed Glioblastoma be Discontinued as it is Unlikely to Meet Primary Overall Survival Endpoint in Patients with Minimal Residual Disease http://ir.celldex.co...

Analysen

Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Celldex Therapeutics Aktie & Unternehmen

Branche Pharmazie
Herkunft USA
Website www.celldextherapeutics.com
Aktienanzahl 98,7 Mio. (Stand: 19.07.16)
Marktkap. 328,7 Mio. $

Dividenden & Splits

12.03.08 Reverse Split 10:1

Ähnliche Aktien

Name
last
change_rel
 
Albireo Pharma 17,001 € -3,57%
Cannabis Science 0,078 € -15,22%
OncoGenex Pharmaceuticals 0,52 € +4,42%
Gilead Sciences 65,39 € -0,59%
Nivalis Therapeutics 1,966 € +2,66%